[144] NEKTAR THERAPEUTICS SEC Filing
Rhea-AI Filing Summary
Nektar Therapeutics insider filing (Form 144) reports proposed sales. The notice lists two recent dispositions: 444 shares sold on 05/19/2026 for $29,084.53 and 10,000 shares sold on 06/16/2026 for $603,137.31. The filing also lists multiple Restricted Stock Vesting entries with specific vested share counts and dates.
Positive
- None.
Negative
- None.
Insights
Form 144 lists proposed dispositions by an insider, with two recent sales documented.
The notice records a 444-share sale on 05/19/2026 for $29,084.53 and a 10,000-share sale on 06/16/2026 for $603,137.31. These are reported as sales on the Form 144 excerpt.
Details such as the seller's title, any Rule 10b5-1 plan, and proceeds recipient are not stated in the excerpt; subsequent filings or broker confirmations would provide that context.